1. , . Neurodegeneration with brain iron accumulation. In: , (eds). Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, 2nd edn. Chichester: Wiley-Blackwell 2011: 446–55.
2. , , , . Hereditary ferritinopathies. In: , (eds). Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, 2nd edn. Chichester, Wiley-Blackwell 2011: 461–6.
3. , , , et al. Neuroimaging features of neurodegeneration with brain iron accumulation. Am J Neuroradiol 2012; 33: 407–14.
4. . Neurodegeneration with brain iron accumulation – clinical syndromes and neuroimaging. Biochim Biophys Acta 2012; 1822: 350–60.
5. , , , et al. Genetics and pathophysiology of neurodegeneration with brain iron accumulation. Curr Neuropharmacol 2013; 11: 59–79.
6. , . Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA). J Neural Transm 2013; 120: 695–703.
7. . The neuropathology of neurodegeneration with brain iron accumulation. Int Rev Neurobiol. 2013; 110: 165–94.
8. , , , et al. Pantothenate kinase-associated neurodegeneration is not a synucleinopathy. Neuropathol Appl Neurobiol 2013; 39:121–31.
9. , , , et al. Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Genet 2011; 89: 543–50.
10. , , , , . Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann NY Acad Sci 2004; 1012: 299–305.
11. . Aceruloplasminemia, an iron metabolic disorder. Neuropathology 2003; 23: 345–50.
12. , , , et al. Hereditary feritinopathy: a novel mutation, its cellular pathology, and pathogenic insights. J Neuropathol Exp Neurol 2005; 64: 280–94.
13. , , , et al. Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498–499InsTC). Mov Disord 2009; 24: 1676–83.
14. , , . Neuroferritinopathy. Int Rev Neurobiol 2013; 110: 91–123.
15. , , . Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol 2044; 63: 363–80.
16. . Ferritinopathy: diagnosis by muscle or nerve biopsy, with a note on other nuclear inclusion-body diseases. Acta Neuropathol 2005; 109: 109–14.
17. , , , et al. Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet 2012; 91: 1144–1149.
18. , , , et al. β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain 2013; 136:1708–17.
19. , , , et al. De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet 2013; 45: 445–9.